ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 668 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,074 | -100.0% | 15 | -100.0% | 0.00% | -100.0% |
Q1 2023 | $2,620,115 | +3.0% | 37,748 | +0.6% | 0.13% | -3.1% |
Q4 2022 | $2,543,513 | +28.6% | 37,515 | +4.0% | 0.13% | +10.1% |
Q3 2022 | $1,978,000 | -25.8% | 36,077 | -10.5% | 0.12% | -22.2% |
Q2 2022 | $2,664,000 | +14.2% | 40,321 | +14.7% | 0.15% | +35.4% |
Q1 2022 | $2,333,000 | +33.1% | 35,166 | +16.8% | 0.11% | +48.7% |
Q4 2021 | $1,753,000 | +3.9% | 30,095 | +7.1% | 0.08% | -3.8% |
Q3 2021 | $1,687,000 | +1.4% | 28,087 | +1.2% | 0.08% | +2.6% |
Q2 2021 | $1,663,000 | +35.8% | 27,763 | +12.8% | 0.08% | +26.2% |
Q1 2021 | $1,225,000 | +1.3% | 24,618 | +1.8% | 0.06% | +1.7% |
Q4 2020 | $1,209,000 | -10.4% | 24,172 | -1.8% | 0.06% | -17.8% |
Q3 2020 | $1,349,000 | +10.2% | 24,612 | +6.4% | 0.07% | +2.8% |
Q2 2020 | $1,224,000 | +22.9% | 23,142 | +3.8% | 0.07% | +1.4% |
Q1 2020 | $996,000 | -21.0% | 22,292 | -11.9% | 0.07% | +1.4% |
Q4 2019 | $1,261,000 | +13.4% | 25,292 | +1.3% | 0.07% | +4.5% |
Q3 2019 | $1,112,000 | +3.2% | 24,956 | -4.4% | 0.07% | +4.8% |
Q2 2019 | $1,077,000 | +6.7% | 26,112 | +4.6% | 0.06% | +1.6% |
Q1 2019 | $1,009,000 | -1.9% | 24,953 | -7.9% | 0.06% | -23.5% |
Q4 2018 | $1,029,000 | +3.9% | 27,097 | +8.4% | 0.08% | +24.6% |
Q3 2018 | $990,000 | +9.9% | 25,001 | -2.6% | 0.06% | +3.2% |
Q2 2018 | $901,000 | +4.0% | 25,673 | +3.7% | 0.06% | +3.3% |
Q1 2018 | $866,000 | -4.2% | 24,746 | -5.0% | 0.06% | -3.2% |
Q4 2017 | $904,000 | +9.7% | 26,040 | +7.0% | 0.06% | +6.8% |
Q3 2017 | $824,000 | +8.3% | 24,330 | +9.0% | 0.06% | +3.5% |
Q2 2017 | $761,000 | +11.3% | 22,327 | +1.7% | 0.06% | +7.5% |
Q1 2017 | $684,000 | +2.1% | 21,950 | -10.5% | 0.05% | -1.9% |
Q4 2016 | $670,000 | -17.2% | 24,530 | -0.3% | 0.05% | -18.2% |
Q3 2016 | $809,000 | +11.4% | 24,616 | +2.3% | 0.07% | +8.2% |
Q2 2016 | $726,000 | +31.0% | 24,069 | +22.2% | 0.06% | +35.6% |
Q1 2016 | $554,000 | -16.7% | 19,698 | +0.6% | 0.04% | -15.1% |
Q4 2015 | $665,000 | +7.8% | 19,589 | +1.0% | 0.05% | +3.9% |
Q3 2015 | $617,000 | -2.7% | 19,395 | +95.0% | 0.05% | +8.5% |
Q2 2015 | $634,000 | – | 9,945 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |